Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

The β-2 agonist debate: is there still a problem?

Patel M, Shirtcliffe P, Beasley R.

Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):58-62. doi: 10.1097/ACI.0b013e32835a5ad9. Review.

PMID:
23037719
2.

Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.

Blanchette CM, Culler SD, Ershoff D, Gutierrez B.

Clin Ther. 2009 Nov;31(11):2574-83. doi: 10.1016/j.clinthera.2009.11.007.

PMID:
20110003
3.

Long-acting β2-agonist step-off in patients with controlled asthma.

Brozek JL, Kraft M, Krishnan JA, Cloutier MM, Lazarus SC, Li JT, Santesso N, Strunk RC, Casale TB.

Arch Intern Med. 2012 Oct 8;172(18):1365-75. Review.

PMID:
22928176
4.

Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.

Chung KF, Caramori G, Adcock IM.

Eur J Clin Pharmacol. 2009 Sep;65(9):853-71. doi: 10.1007/s00228-009-0682-z. Epub 2009 Jun 26. Review.

PMID:
19557399
5.

Characterization of long-acting beta₂-adrenergic agonists utilization in asthma patients.

Kaplan S, Zhou EH, Iyasu S.

J Asthma. 2012 Dec;49(10):1079-85. doi: 10.3109/02770903.2012.733990. Epub 2012 Oct 30.

PMID:
23106094
6.

Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.

Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.

Curr Med Res Opin. 2009 Sep;25(9):2251-8. doi: 10.1185/03007990903155915.

PMID:
19622006
7.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ducharme FM, Lasserson TJ, Cates CJ.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003137. Review. Update in: Cochrane Database Syst Rev. 2011;(5):CD003137.

PMID:
17054161
8.
9.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.

Main C, Shepherd J, Anderson R, Rogers G, Thompson-Coon J, Liu Z, Hartwell D, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(20):1-174, iii-iv. Review.

10.

[Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process].

Kardos P, Bechtel B, Palovis L, Hagedorn C, Latif F.

Pneumologie. 2012 Sep;66(9):549-57. doi: 10.1055/s-0032-1310076. Epub 2012 Aug 16.

11.

Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.

Gibson PG, Powell H, Ducharme F.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005076. Review.

PMID:
16235393
12.

Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.

Ram FS, Cates CJ, Ducharme FM.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003137. Review. Update in: Cochrane Database Syst Rev. 2006;(4):CD003137.

PMID:
15674901
13.
14.

Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.

Shepherd J, Rogers G, Anderson R, Main C, Thompson-Coon J, Hartwell D, Liu Z, Loveman E, Green C, Pitt M, Stein K, Harris P, Frampton GK, Smith M, Takeda A, Price A, Welch K, Somerville M.

Health Technol Assess. 2008 May;12(19):iii-iv, 1-360. Review.

15.

Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps.

Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, Jenkins CR, Peterson S, Ostlund O, O'Byrne PM, Sears MR, Eriksson GS.

Respir Res. 2011 Apr 4;12:38. doi: 10.1186/1465-9921-12-38.

16.

Initial step-up treatment changes in asthmatic children already prescribed inhaled corticosteroids: a historical cohort study.

Turner SW, Richardson K, Burden A, Thomas M, Murray C, Price D.

NPJ Prim Care Respir Med. 2015 Jun 11;25:15041. doi: 10.1038/npjpcrm.2015.41.

17.
18.

Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.

Greenstone IR, Ni Chroinin MN, Masse V, Danish A, Magdalinos H, Zhang X, Ducharme FM.

Cochrane Database Syst Rev. 2005 Oct 19;(4):CD005533. Review. Update in: Cochrane Database Syst Rev. 2010;(4):CD005533.

PMID:
16235409
19.
20.

Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.

Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.

Clin Ther. 2009 May;31(5):1056-63. doi: 10.1016/j.clinthera.2009.05.008.

PMID:
19539106

Supplemental Content

Support Center